VALOVÁ, Simona, Petra BOŘILOVÁ LINHARTOVÁ, Lucie MASOPUSTOVÁ, Jiřina BÁRTOVÁ, Jitka PETANOVÁ, Pavel KUKLÍNEK, Antonín FASSMANN a Lydie IZAKOVIČOVÁ HOLLÁ. The NOD-like receptor (NLRP3) gene variability in patients with recurrent aphthous stomatitis. In 8th European Immunology Conference, Madrid, Spain. 2017. ISSN 2155-9899.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The NOD-like receptor (NLRP3) gene variability in patients with recurrent aphthous stomatitis
Autoři VALOVÁ, Simona (203 Česká republika, domácí), Petra BOŘILOVÁ LINHARTOVÁ (203 Česká republika, domácí), Lucie MASOPUSTOVÁ (203 Česká republika, domácí), Jiřina BÁRTOVÁ (203 Česká republika), Jitka PETANOVÁ (203 Česká republika), Pavel KUKLÍNEK (203 Česká republika, domácí), Antonín FASSMANN (203 Česká republika, domácí) a Lydie IZAKOVIČOVÁ HOLLÁ (203 Česká republika, garant, domácí).
Vydání 8th European Immunology Conference, Madrid, Spain, 2017.
Další údaje
Originální jazyk angličtina
Typ výsledku Konferenční abstrakt
Obor 30208 Dentistry, oral surgery and medicine
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Kód RIV RIV/00216224:14110/17:00100712
Organizační jednotka Lékařská fakulta
ISSN 2155-9899
Klíčová slova anglicky recurrent aphthous stomatitis; NLRP3; polymorphism
Změnil Změnila: Mgr. et Mgr. Simona Slezáková, Ph.D., učo 357612. Změněno: 18. 1. 2019 13:26.
Anotace
Statement of the Problem: Recurrent aphthous stomatitis (RAS) is a multifactorial disease with an unclear etiopathogenesis, resulting from the interplay between genetic and environmental factors. As the dysregulation of the immune system can play a role in the RAS development, single nucleotide polymorphisms (SNPs) in the genes for immune and inflammatory molecules were studied. The NOD-like receptor (NLRP3) gene, encoding the component of the inflammasome, has been proposed as one of the candidate genes for RAS. The aim of our study was to investigate three SNPs (rs4612666, rs10754558, rs3806265) in NLRP3 gene in patients with RAS and healthy controls in the Caucasian population Methodology: A total of 200 Czech subjects were enrolled in this case-control study. 143 healthy controls, 57 patients with RAS were genotyped by method based on polymerase chain reaction using 5´ nuclease TaqMan assays. Clinical parameters such as complete blood count, levels of immunoglobulins including allergen-specific immunoglobulin E or presence of antibodies against cytomegalovirus, Epstein-Barr virus were determined in RAS patients. Findings: Although no significant differences in the NLRP3 (rs10754558, rs3806265) allele and genotype frequencies between patients with RAS and controls were observed, statistically significant differences in NLRP3 rs4612666 genotype frequencies between subjects with RAS and controls were found. Carriers of NLRP3 rs4612666 TT genotype had a higher risk of developing RAS in comparison to subjects with CT + CC genotypes (OR = 16.71, 95% CI = 1.96-142.14, P = 0.0024). No association between NLRP3 haplotypes and RAS was detected. Conclusion; Significance: In contrast to the previous study5, associations between NLRP3 (rs10754558, rs3806265) polymorphisms and RAS were not confirmed. However, we suggest that NLRP3 rs4612666 polymorphism can strongly influence the risk of developing RAS in the Czech population.
Návaznosti
GB14-37368G, projekt VaVNázev: Centrum orofaciálního vývoje a regenerace
Investor: Grantová agentura ČR, Centrum orofaciálního vývoje a regenerace
MUNI/A/0948/2016, interní kód MUNázev: Nemoci dutiny ústní – etiopatogeneze, klinické projevy, diagnostika a léčba
Investor: Masarykova univerzita, Nemoci dutiny ústní – etiopatogeneze, klinické projevy, diagnostika a léčba, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty
NV15-29336A, projekt VaVNázev: Změny imunologické reaktivity u pacientů s recidivujícími aftami
VytisknoutZobrazeno: 26. 4. 2024 09:47